Archive: 21/04/2016

Identification of therapeutic targets in multiple myeloma

Multiple myeloma (MM) is a hematological cancer that frequently acquires resistance to chemotherapeutic drugs. Additionally, many patients experience disease relapse, but these patients are difficult to treat as the cancer ...

page 3 from 9